Indian obesity pharma market is in a dramatic change with the records being broken by Eli Lilly’s Mounjaro (tirzepatide) going over ₹100 crore in sales in only four months of launch in March 2025. The speed of adoption reveals an increasing need for effective, low-cost weight-loss drugs as India witnesses an increase in obesity and … Continue reading Mounjaro Sales Hit ₹100 Crore in 4 Months A Game-Changer for India’s Obesity Market